Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow MEDICINOVA INC

Get SEC filing alerts via email and in your feed for MEDICINOVA INC

MNOV

MEDICINOVA INC

About MEDICINOVA INC

MediciNova, Inc. is a biopharmaceutical company developing novel therapeutics for serious diseases with unmet medical needs. Its focus includes neurological disorders, fibrotic and metabolic conditions, and cancer. Core products MN-166 (ibudilast) and MN-001 (tipelukast) target multiple indications such as multiple sclerosis, ALS, addiction, liver disease, and glioblastoma. The company advances its pipeline through clinical trials, strategic partnerships, and intellectual property protections.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from MEDICINOVA INC

1
1
MEDICINOVA INC MediciNova Reports $186,984 Revenue in Q1 2026, Operating Loss Decreases

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
MEDICINOVA INC MediciNova Reports $12M Net Loss and $409K Revenue for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
MEDICINOVA INC MediciNova Reports Q3 2025 Revenue of $123,319, Operating Loss of $3.38M

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
MEDICINOVA INC MediciNova Reports $134,599 Revenue in Q2 2025, Faces $3.3 Million Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
MEDICINOVA INC MediciNova Reports Q1 2025 Financial Results with $2.86 Million Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
MEDICINOVA INC MediciNova Reports $11M Net Loss for Fiscal Year 2024, Revenues Drop to $0

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
MEDICINOVA INC MediciNova Reports Significant Revenue Decline and Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments